CRISPR-based Phage Therapy Shines in the First Human Trial June 1, 2023 SNIPR Biome, a Danish microbiome technology company, has unveiled promising results from the initial phase of their groundbreaking CRISPR-based phage therapy targeting Escherichia coli…
BiomX Reveals Promising Results in First Bacteriophage Trial on patients with cystic fibrosis (CF) February 28, 2023 Exciting news from the field of medical research! A recent study conducted by BiomX has shown promising results for the use of bacteriophages as…
